| 000 | 01002 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250512071629.0 | ||
| 264 | 0 | _c19861204 | |
| 008 | 198612s 0 0 eng d | ||
| 022 | _a0361-5960 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCantwell, B M | |
| 245 | 0 | 0 |
_aPhase II study of a novel antifolate, N10-propargyl-5,8 dideazafolic acid (CB3717), in malignant mesothelioma. _h[electronic resource] |
| 260 |
_bCancer treatment reports _cNov 1986 |
||
| 300 |
_a1335-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 |
_aFolic Acid _xadverse effects |
| 650 | 0 | 4 |
_aFolic Acid Antagonists _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMesothelioma _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aQuinazolines _xadverse effects |
| 700 | 1 | _aEarnshaw, M | |
| 700 | 1 | _aHarris, A L | |
| 773 | 0 |
_tCancer treatment reports _gvol. 70 _gno. 11 _gp. 1335-6 |
|
| 999 |
_c3774577 _d3774577 |
||